GILD
GILEAD SCIENCES, INC.F1915-min delayed · EOD close149.69 −1.11% downas of 2026-09-24mkt cap $186B
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0000882095
Quality score
19/100
F
Growth18
Business quality0
missing: grossMargin
Financial healthno data
missing: debtToEquity, cashToLiabilities
Valuation40
missing: peRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Weak on most measures
Uneven
Strongest on valuation (40), weakest on business quality (0). The composite is the mean of the sub-scores that could be computed. 4 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
7.8%
year over year
Earnings growth